Testing effectiveness (Phase 2)Ended earlyNCT01598103
What this trial is testing
Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
Who this might be right for
Neurogenic Urinary BladderNeurogenic Bladder DisorderNeurogenic Dysfunction of the Urinary Bladder+2 more
Novartis Pharmaceuticals 9